• Comparison of the activities of wild type and mutant enhancing factor/mouse secretory phospholipase A2 proteins

    • Fulltext


        Click here to view fulltext PDF

      Permanent link:

    • Keywords


      Enhancing factor; epidermal growth factor; heparin binding; phospholipase A2; site-directed mutagenesis

    • Abstract


      Enhancing factor (EF) protein, an isoform of secretory phospholipase A2 (PLA2), was purified as a modulator of epidermal growth factor from the small intestine of the Balb/c mouse. It was for the first time that a growth modulatory property of sPLA2 was demonstrated. Deletion mutation analysis of EF cDNA carried out in our laboratory showed that enhancing activity and phospholipase activity are two separate activities that reside in the same molecule. In order to study the specific amino acids involved in each of these activities, two site-directed mutants of EF were made and expressedin vitro. Comparison of enhancing activity as well as phospholipase A2 activity of these mutant proteins with that of wild type protein helped in identification of some of the residues important for both the activities.

    • Author Affiliations


      Bhakti M Kirtane1 Rita Mulherkar1

      1. Laboratory of Genetic Engineering, Cancer Research Institute, Tata Memorial Centre, Parel, Mumbai - 400 012, India
    • Dates

  • Journal of Biosciences | News

    • Editorial Note on Continuous Article Publication

      Posted on July 25, 2019

      Click here for Editorial Note on CAP Mode

© 2017-2019 Indian Academy of Sciences, Bengaluru.